Event Highlights
Clinical Applications of Tumour-Treating Fields in Glioblastoma

Glioblastoma is the most common and aggressive primary brain tumour. While glioblastoma can occur at any age, it tends to occur more often in older adults. The disease course is typically rapid, with only approximately 1 in 4 patients alive 2 years ...

Dec 22, 2022
Updates on XEN Gel Stent Implantation and Fixed-dose Combination Eye Drops

Ocular surface disease (OSD) is a multifactorial disease of the ocular surface that results in symptomatic discomfort, visual disturbances, and tear film instability with progressive histopathologic and clinical changes to the ocular surface. OSD is...

Dec 22, 2022
Optimising Treatment Outcomes of RET Fusion-positive NSCLC

Non-small cell lung cancer (NSCLC) is one of the leading causes of death globally. In recent years, the identification of multiple molecular alterations in NSCLC has led to the development of target-based therapies, which have shown significant clin...

Dec 22, 2022
The Annual Scientific Meeting of the Hong Kong Movement Disorder 2022

The Hong Kong Movement Disorder Society (HKMDS) is a local organisation aims to advance the knowledge and treatment of movement disorders to health professionals and public, to enhance researches in this field, and to facilitate academic collaborati...

Dec 22, 2022
Hybrid Lecture on Overcoming the Resistance of Relapsed and Refractory Multiple Myeloma

The immunomodulatory drugs (IMiDs), lenalidomide-based therapies in particular, have significantly improved the survival of patients with multiple myeloma (MM), and thus are recommended in various clinical guidelines. Nonetheless, a substantial prop...

Sep 23, 2022
Scientific Webinar on Biologics Treatment in CRSwNP

Chronic rhinosinusitis with nasal polyposis (CRSwNP) is a predominantly type 2 inflammation-mediated disease of the nasal mucosa and paranasal sinuses. The disease is characterised grossly by grape-like projections of inflammatory polyps within the ...

Sep 23, 2022
Webinar on Heart and Kidney Protection with SGLT2 inhibitors in T2DM

Type 2 diabetes mellitus (T2DM) is a prevalent disease with the severe clinical implications including myocardial infarction, stroke, and kidney disease. While therapies focusing on glycemic control in T2DM have largely failed to substantially impro...

Sep 23, 2022
The Kidneys Talk Season 2 cum the Launching Ceremony of the World Kidney Day in Hong Kong 2022

The “Kidneys Talk” Channel is a live channel organised by the Hong Kong Kidney Foundation (HKKF), with the Hong Kong Society of Nephrology (HKSN) and the Hong Kong Association of Renal Nurses (HKARN) as the co-organisers. The channel aim...

Sep 23, 2022
Webinar on the Role of Immunomodulatory Drugs in Multiple Myeloma

While management of relapsed and refractory multiple myeloma (RRMM) is still a challenging clinical problem, there is emerging evidence demonstrating the benefits of immunomodulatory drugs (IMiDs)-based regimens in controlling the disease. Nonethele...

Jun 17, 2022
Stay Tuned to the “Kidneys Talk” Season 2

Season 2 of the “Kidneys Talk” will officially be live on 9 th July 2022 and every other Tuesday for a total of 9 episodes. Brought to you by a local non-profit making voluntary organization, the Hong Kong Kidney Foundation (HKKF). Their...

Jun 17, 2022
The Heart Failure Society of America-Asia Pacific Advanced Heart Failure Forum 2022

Co-organized by the Chinese University of Hong Kong (CUHK) and Heart Failure Society of America (HFSA), the Asia Pacific Advanced Heart Failure Forum was held on 7th May at the Hong Kong Science Park. The forum was a hybrid event of virtual broadcas...

Jun 17, 2022
Virtual Symposium on Perioperative Care for Geriatric Patients Undergoing Surgery

Despite the increasing longevity of the worldwide population, the elderly is a group of individuals commonly faced with increased morbidities that would have necessitated them receiving surgical and non-surgical procedures with anaesthesia. However,...

Jun 17, 2022